Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Net Margin: 2020-2025

Historic Net Margin for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 92.73%.

  • Pharming Group N.V's Net Margin rose 8384.00% to 92.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 42.76%, marking a year-over-year increase of 5275.00%. This contributed to the annual value of -4.03% for FY2024, which is 275.00% down from last year.
  • Latest data reveals that Pharming Group N.V reported Net Margin of 92.73% as of Q3 2025, which was up 109.52% from -973.58% recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Net Margin ranged from a high of 92.73% in Q3 2025 and a low of -973.58% during Q2 2025.
  • Over the past 3 years, Pharming Group N.V's median Net Margin value was -7.76% (recorded in 2023), while the average stood at -98.05%.
  • Data for Pharming Group N.V's Net Margin shows a peak YoY increase of 8,384bps (in 2025) and a maximum YoY decrease of 94,692bps (in 2025) over the last 5 years.
  • Pharming Group N.V's Net Margin (Quarterly) stood at 2.87% in 2021, then plummeted by 625bps to -3.38% in 2022, then soared by 964bps to 6.27% in 2023, then skyrocketed by 77bps to 7.04% in 2024, then soared by 8,384bps to 92.73% in 2025.
  • Its Net Margin stands at 92.73% for Q3 2025, versus -973.58% for Q2 2025 and 7.04% for Q4 2024.